Park SH - Search Results

1

Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.

Merz VW, Miller GJ, Krebs T, Timme TL, Kadmon D, Park SH, Egawa S, Scardino PT, Thompson TC. Merz VW, et al. Among authors: park sh. Mol Endocrinol. 1991 Apr;5(4):503-13. doi: 10.1210/mend-5-4-503. Mol Endocrinol. 1991. PMID: 1922083

2

Transforming growth factor beta 1 as a biomarker for prostate cancer.

Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH. Thompson TC, et al. Among authors: park sh. J Cell Biochem Suppl. 1992;16H:54-61. doi: 10.1002/jcb.240501212. J Cell Biochem Suppl. 1992. PMID: 1289674 Review.

3

Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas.

Thompson TC, Egawa S, Kadmon D, Miller GJ, Timme TL, Scardino PT, Park SH. Thompson TC, et al. Among authors: park sh. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):79-85. doi: 10.1016/0960-0760(92)90190-t. J Steroid Biochem Mol Biol. 1992. PMID: 1525069

4

Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation.

Lu X, Park SH, Thompson TC, Lane DP. Lu X, et al. Among authors: park sh. Cell. 1992 Jul 10;70(1):153-61. doi: 10.1016/0092-8674(92)90541-j. Cell. 1992. PMID: 1623518

5

Experimental oncogene induced prostate cancer.

Thompson TC, Kadmon D, Timme TL, Merz VW, Egawa S, Krebs T, Scardino PT, Park SH. Thompson TC, et al. Among authors: park sh. Cancer Surv. 1991;11:55-71. Cancer Surv. 1991. PMID: 1726789

6

Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.

Thompson TC, Park SH, Timme TL, Ren C, Eastham JA, Donehower LA, Bradley A, Kadmon D, Yang G. Thompson TC, et al. Among authors: park sh. Oncogene. 1995 Mar 2;10(5):869-79. Oncogene. 1995. PMID: 7534899

7

Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.

Timme TL, Truong LD, Slawin KM, Kadmon D, Park SH, Thompson TC. Timme TL, et al. Among authors: park sh. Microsc Res Tech. 1995 Mar 1;30(4):333-41. doi: 10.1002/jemt.1070300408. Microsc Res Tech. 1995. PMID: 7541677 Review.

8

Effects of genetic background on tumorigenesis in p53-deficient mice.

Donehower LA, Harvey M, Vogel H, McArthur MJ, Montgomery CA Jr, Park SH, Thompson T, Ford RJ, Bradley A. Donehower LA, et al. Among authors: park sh. Mol Carcinog. 1995 Sep;14(1):16-22. doi: 10.1002/mc.2940140105. Mol Carcinog. 1995. PMID: 7546219

9

DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.

Greene DR, Taylor SR, Aihara M, Yoshida K, Egawa S, Park SH, Timme TL, Yang G, Scardino PT, Thompson TC. Greene DR, et al. Among authors: park sh. Int J Cancer. 1995 Jan 27;60(3):395-9. doi: 10.1002/ijc.2910600321. Int J Cancer. 1995. PMID: 7829250

10

Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis.

Timme TL, Truong LD, Merz VW, Krebs T, Kadmon D, Flanders KC, Park SH, Thompson TC. Timme TL, et al. Among authors: park sh. Endocrinology. 1994 Mar;134(3):1039-45. doi: 10.1210/endo.134.3.8119140. Endocrinology. 1994. PMID: 8119140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,146 results

Search Page

Filters